<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.01">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.01" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-107005-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Determination of Mucosal Secretory Factors that Influence Susceptibility to HIV Infection Among Female Sex Workers in Kenya</narrative>
   <narrative xml:lang="FR">D&#xE9;termination des facteurs de s&#xE9;cr&#xE9;tion des muqueuses influant sur la vuln&#xE9;rabilit&#xE9; &#xE0; l&apos;infection par le VIH chez les travailleuses du sexe au Kenya</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Il est crucial de comprendre les facteurs complexes pouvant mener &#xE0; l&apos;infection par le VIH afin de s&apos;attaquer au probl&#xE8;me chez les populations vuln&#xE9;rables, telles que les travailleuses du sexe. En 2010, l&apos;Initiative de recherche en sant&#xE9; mondiale a accord&#xE9; une subvention de 1,8 million de dollars &#xE0; la Kenya AIDS Vaccine Initiative (KAVI) afin de renforcer les capacit&#xE9;s de recherche en Afrique pour des essais en mati&#xE8;re de pr&#xE9;vention du VIH/sida. 

Depuis, la KAVI a pris des mesures pour devenir un Centre d&apos;excellence r&#xE9;gional en mati&#xE8;re d&apos;immunologie mucosale au Kenya et en Afrique de l&apos;Est. L&apos;immunologie mucosale s&apos;int&#xE9;resse aux parties du corps par lesquelles la plupart des antig&#xE8;nes p&#xE9;n&#xE8;trent dans l&apos;organisme, ce qui comprend les surfaces des appareils gastro-intestinal, respiratoire et urog&#xE9;nital. La KAVI vise &#xE0; mettre sur pied un centre de formation en recherche clinique afin de former de nouveaux chercheurs, y compris des candidats au doctorat. 

Ce projet fera mieux conna&#xEE;tre l&apos;immunologie des muqueuses g&#xE9;nitales dans les cas d&apos;infection par le VIH. Il se concentrera particuli&#xE8;rement sur l&apos;expression des antig&#xE8;nes pr&#xE9;sents dans le sang, qui produisent des anticorps, et sur l&apos;&#xE9;pith&#xE9;lium de l&apos;appareil g&#xE9;nital de la femme, le premier point de contact de l&apos;h&#xF4;te avec le VIH. Il &#xE9;tudiera aussi certaines associations possibles avec l&apos;&#xE9;tablissement de l&apos;infection par le VIH. Les constatations pourraient permettre une meilleure compr&#xE9;hension du m&#xE9;canisme de protection des muqueuses et faciliter la mise au point de nouvelles technologies de pr&#xE9;vention du VIH.</narrative>
   <narrative xml:lang="EN">Understanding the complex factors that can lead to HIV infection is crucial to addressing the problem among vulnerable populations, such as female sex workers. In 2010, the Global Health Research Initiative awarded a $1.8 million grant to the Kenya AIDS Vaccine Initiative (KAVI) to build research capacity in Africa for HIV/AIDS prevention trials. 

Since that time, KAVI has taken steps to become a regional Centre of Excellence for Mucosal Immunology in Kenya and East Africa. Mucosal immunology focuses on the sites at which most antigens enter the body, which include surfaces of the gastrointestinal, respiratory, and urogenital tracts. KAVI aims to establish a clinical research training centre to train new researchers, including PhD candidates. 

This project will shed light on the genital mucosal immunology of HIV infections. It will specifically focus on the expression of blood antigens, which produce antibodies, on the female genital tract epithelium, the earliest point of HIV host contact. It will also examine potential associations with the establishment of HIV infection. Findings may provide further insight into the mucosal protection mechanism and contribute to the development of new HIV preventive technologies.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
   <narrative xml:lang="EN">Canadian International Development Agency</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="60">
   <narrative xml:lang="EN">University of Nairobi</narrative>
  </participating-org>
  <participating-org role="4" type="60">
   <narrative xml:lang="EN">University of Nairobi</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2012-03-05" type="2"></activity-date>
  <activity-date iso-date="2014-09-05" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="KE" percentage="100"></recipient-country>
  <sector code="00003" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Children and Youth</narrative>
   <narrative xml:lang="FR">Enfants et jeunes</narrative>
  </sector>
  <sector code="13040" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="1" vocabulary="1"></policy-marker>
  <policy-marker code="101" significance="2" vocabulary="99"></policy-marker>
  <policy-marker code="102" significance="0" vocabulary="99"></policy-marker>
  <policy-marker code="103" significance="0" vocabulary="99"></policy-marker>
  <policy-marker code="104" significance="0" vocabulary="99"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2012-03-31"></transaction-date>
   <value currency="CAD" value-date="2012-03-31">50000</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Nairobi</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2012-03-31"></transaction-date>
   <value currency="CAD" value-date="2012-03-31">37000</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Nairobi</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2013-05-31"></transaction-date>
   <value currency="CAD" value-date="2013-05-31">9500</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Nairobi</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2014-09-30"></transaction-date>
   <value currency="CAD" value-date="2014-09-30">-5264</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Nairobi</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2014-10-31"></transaction-date>
   <value currency="CAD" value-date="2014-10-31">-8764</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Nairobi</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
